Heading to
#ASGCT in Boston? You may want to come see us at Booth #1549 for the free coffee. You’ll definitely want to stick around for the eye-opening science.
And there’ll be a lot of it.
In short: Viralgen will be all over ASGCT, sharing posters highlighting new AAV-based gene therapy research, leading a talk on plasmid optimization services, and hosting a lunch symposium on innovative approaches to accelerating the path from development to rare disease patients. (Want details? Just keep reading. Or find us at Booth #1549 and we’ll be happy to fill you in.)
But don’t worry—even in the midst of all this activity, we’re eager to make time for you. In fact, we hope you’ll use the link below to sign up for some one-on-one time to discuss your specific questions and challenges.
lnkd.in/eNX9susB
Viralgen @ ASGCT
60 Minute Lunch Symposium
A Platform’s Path to Rare Disease Patients: Accelerating AAV Manufacturing from Development to Commercialization
Wednesday, 12:15-1:15pm, 107ABC
Featuring Adrian Stecyk (
@MyrtelleInc ), Andrew Steinsapir (
@Apertura_GTX ), Craig Martin (Orphan Therapeutics Accelerator), Christine Green (
@Hope4FRRS1L ), and Viralgen’s Cesar Trigueros
Tools & Technology Presentation
Plasmid Optimization Services: Key Insights from a Case Study Showing how to Successfully Manufacture an AAV Product
Led by Leticia Agúndez Agundez - TAAV Biomanufacturing Solutions
Wednesday, 10:15-10:30am, Exhibit Hall Presentation Theater
Posters
Emilie Lecomte
Repeatability and intermediate precision of a genome integrity assay for rAAV by long-read sequencing
Reception: Tuesday, 5:00-6:30pm
Maria Garcia
ddPCR-based Quantification and Fragment Analysis of Residual E1A in rAAV Products: Method Validation and Correlation with Total Host Cell DNA
Reception: Tuesday, 5:00-6:30pm
Ainara Apezteguía
Multivariate approach to Small-Scale Model Qualification (SSMQ) in Upstream (USP) adeno-associated virus (AAV) production
Reception: Thursday, 5:00-6:30pm
#ASGCT #GeneTherapy #AAV #CellandGeneTherapy #AllInAAV